공연
RD 인기지표
RD 성장지표
비교
팔로우 목록
인물
BNB Plus 소개
BNB Plus is a Nasdaq-listed digital asset treasury company trading under the ticker BNBX. It began as a biotechnology firm and, after the pivot, holds BNB as its main balance-sheet asset while keeping a nucleic acid production business as an operating revenue line. Its pitch is BNB exposure for US brokerage accounts without a wallet or an exchange account.
The treasury runs four layers: native staking for block rewards, participation in ecosystem incentive programmes, liquidity provision on PancakeSwap for swap fees, and non-directional strategies collateralised by holdings. Positions are managed by token count rather than a fixed dollar amount, with the aim of raising BNB per share over time, so yield is converted back into BNB instead of distributed. In July 2026 the company disclosed a Nasdaq delisting determination and moved to the OTCQB market, and in September of the same year announced a shift toward institutional technology infrastructure and monetisation of assets.
BNB Plus (BNBX, formerly Applied DNA Sciences) — latest results: Q3 FY2026 (quarter ended June 30, 2026): revenue of USD 0.605 million, net loss of USD 4.69 million, EPS of USD (0.57), operating loss of USD 1.90 million, gross margin 69%, operating cash flow --, total assets of USD 14.96 million, digital asset holdings of 2,186 BNB directly (fair value approximately USD 1.20 million) plus OBNB Trust Units (fair value approximately USD 4.53 million), active users --. The business centers on a BNB digital-asset treasury strategy, while commercializing nucleic-acid production solutions via its LineaRx subsidiary (LineaDNA / LineaRNAP / LineaIVT for biopharma and diagnostics), and also includes DNA tagging and security products and services. Revenue rose approximately 99% year over year (product revenue +200%, service revenue -82%), and the net loss widened from USD 3.95 million to USD 4.69 million. Management stated current cash, equivalents and liquid crypto assets are sufficient to fund operations for at least the next twelve months, and plans to keep expanding BNB reserves and pursue yield in the Binance and DeFi ecosystems. The main risks are delisting from Nasdaq to the OTCQB, recurring net losses (accumulated deficit approximately USD 409 million) and sharp BNB price volatility.